Literature DB >> 8823152

Metabolic precursors of hypertension. The San Antonio Heart Study.

S M Haffner1, H Miettinen, S P Gaskill, M P Stern.   

Abstract

BACKGROUND: The relation of possible metabolic precursors (especially insulin resistance) to hypertension has been controversial. In addition, these associations may differ by level of obesity or ethnicity.
METHODS: We followed up 1039 initially nondiabetic, nonhypertensive subjects from the San Antonio Heart Study for 7 years.
RESULTS: Hypertension developed in 93 subjects. Age, body mass index, waist-to-hip ratio, and fasting insulin and triglyceride levels predicted the development of hypertension in univariate analyses. After adjustment for age, body mass index, waist-to-hip ratio, gender, ethnicity, and fasting glucose levels, higher levels of triglyceride and fasting insulin predicted the development of hypertension. Body mass index and fasting insulin and triglyceride levels predicted the development of hypertension in Mexican Americans and non-Hispanic whites. In addition, fasting insulin levels predicted the development of hypertension in lean and obese subjects. Increased insulin secretion (as judged by the 30-minute insulin increment) on an oral glucose tolerance test also predicted the development of hypertension.
CONCLUSIONS: A cluster of atherogenic changes may precede the development of hypertension, and increased fasting insulin concentration predicts hypertension in important subgroups of subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823152

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  18 in total

1.  Dyslipidaemia as a predictor of hypertension in middle-aged men.

Authors:  David E Laaksonen; Leo Niskanen; Kristiina Nyyssönen; Timo A Lakka; Jari A Laukkanen; Jukka T Salonen
Journal:  Eur Heart J       Date:  2008-02-28       Impact factor: 29.983

2.  Insulin resistance and risk of incident hypertension among men.

Authors:  Tai-Shuan Lai; Gary C Curhan; John P Forman
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-09       Impact factor: 3.738

3.  Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance.

Authors: 
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

Review 4.  Hypertension and insulin disorders.

Authors:  Michinori Imazu
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

5.  Comparison of anthropometric indices as predictors of the risk factors for cardiovascular disease in Iran: The PERSIAN Guilan Cohort Study.

Authors:  Marjan Mahdavi-Roshan; Arezoo Rezazadeh; Farahnaz Joukar; Mohammadreza Naghipour; Soheil Hassanipour; Fariborz Mansour-Ghanaei
Journal:  Anatol J Cardiol       Date:  2021-02       Impact factor: 1.596

6.  A retrospective cohort study on obesity and hypertension risk among Korean adults.

Authors:  Sung-Hee Lee; Young-Sik Kim; Sung Sunwoo; Bong-Yul Huh
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

7.  Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study.

Authors:  Susan Cheng; Vanessa Xanthakis; Lisa M Sullivan; Ramachandran S Vasan
Journal:  Hypertension       Date:  2012-10-29       Impact factor: 10.190

Review 8.  Obesity and mortality: are the risks declining? Evidence from multiple prospective studies in the United States.

Authors:  T Mehta; K R Fontaine; S W Keith; S S Bangalore; G de los Campos; A Bartolucci; N M Pajewski; D B Allison
Journal:  Obes Rev       Date:  2014-06-09       Impact factor: 9.213

9.  Reduced heart rate variability is associated with worse cognitive performance in elderly Mexican Americans.

Authors:  Adina Zeki Al Hazzouri; Mary N Haan; Yingzi Deng; John Neuhaus; Kristine Yaffe
Journal:  Hypertension       Date:  2013-10-21       Impact factor: 10.190

10.  A novel indicator, childhood lipid accumulation product, is associated with hypertension in Chinese children and adolescents.

Authors:  Yuan Wang; Wenmin Liu; Lili Sun; Yifei Zhang; Bangxuan Wang; Yongting Yuan; Ting Li; Rongying Yao; Hui Han; Qingwen Qian; Lianguo Fu
Journal:  Hypertens Res       Date:  2019-12-09       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.